Apoptosis(凋亡)
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
Products for Apoptosis
- Caspase(85)
- 14.3.3 Proteins(1)
- Apoptosis Inducers(43)
- Bax(7)
- Bcl-2 Family(106)
- Bcl-xL(8)
- c-RET(9)
- IAP(26)
- KEAP1-Nrf2(64)
- MDM2(12)
- p53(112)
- PC-PLC(4)
- PKD(8)
- RasGAP (Ras- P21)(1)
- Survivin(6)
- Thymidylate Synthase(10)
- TNF-α(128)
- Other Apoptosis(885)
- APC(5)
- PD-1/PD-L1 interaction(60)
- ASK1(3)
- PAR4(2)
- RIP kinase(50)
- FKBP(19)
- Pyroptosis(30)
- Cat.No. 产品名称 Information
-
GC47187
Deoxycholic Acid-d4
去氧胆酸 d4
An internal standard for the quantification of deoxycholic acid -
GC47167
Dacarbazine-d6
达卡巴嗪-D6,Imidazole Carboxamide-d6
An internal standard for the quantification of dacarbazine -
GC47166
Dabrafenib-d9
达帕菲尼杂质,GSK2118436A-d9; GSK2118436-d9
An internal standard for the quantification of dabrafenib -
GC47148
Cyclophosphamide-d4
环磷酰胺 d4
An internal standard for the quantification of cyclophosphamide - GC47105 Clonostachydiol A fungal metabolite with anticancer and anthelmintic activities
- GC47098 CL2-SN-38 (dichloroacetic acid salt) An antibody-drug conjugate containing SN-38
- GC47073 Ceramides (hydroxy) A mixture of hydroxy fatty acid-containing ceramides
-
GC47070
Celecoxib-d7
塞来昔布-D7,SC 58635-d7
An internal standard for the quantification of celecoxib - GC47065 CAY10773 A derivative of sorafenib
- GC47061 CAY10763 A dual inhibitor of IDO1 and STAT3 activation
- GC47057 CAY10755 A fungal metabolite with anticancer activity
- GC47055 CAY10749 A dual inhibitor of PARP and PI3K
- GC47053 CAY10746 A ROCK1 and ROCK2 inhibitor
- GC47051 CAY10740 (hydrochloride) A neuropeptide with diverse biological activities
-
GC47042
Carfilzomib-d8
来那度胺-D8
An internal standard for the quantification of carfilzomib -
GC47016
Cabergoline-d6
FCE-21336-d6
A neuropeptide with diverse biological activities -
GC46989
C18 dihydro Ceramide-d3 (d18:0/18:0-d3)
N-octadecanoyl-D-erythro-Dihydrosphingosine-d3
An internal standard for the quantification of C18 dihydro ceramide -
GC46976
C16 Ceramide-d7 (d18:1-d7/16:0)
Palmitoyl Ceramide-d7
An internal standard for the quantification of C16 ceramide -
GC46962
Busulfan-d8
白消安 d8
An internal standard for the quantification of busulfan -
GC46942
Bortezomib-d15
LDP-341-d15, MG-341-d15, PS-341-d15
A neuropeptide with diverse biological activities -
GC46914
Bendamustine-d4 (hydrochloride)
盐酸苯达莫司汀 d4 (盐酸盐)
A neuropeptide with diverse biological activities -
GC46904
Azoxystrobin
嘧菌酯
A broad-spectrum fungicide -
GC46901
Azadirachtin
印楝素
A naturally-occurring insecticide -
GC46895
Aurintricarboxylic Acid (ammonium salt)
铝试剂
A protein synthesis inhibitor with diverse biological activities - GC46892 ATRA-BA Hybrid A prodrug form of all-trans retinoic acid and butyric acid
-
GC46882
Artemisinin-d3
Qinghaosu-d3; NSC 369397-d3
An internal standard for the quantification of artemisinin -
GC46878
Aranciamycin
阿雷西霉素
A fungal metabolite with diverse biological activities -
GC46862
Apigenin-d5
3,6,8,3’,5’-d5-Apigenin, Chamomile-d5, Flavone-d5, Versulin-d5
An internal standard for the quantification of apigenin - GC46821 Ajoene A disulfide with antitumor and antiplatelet activities
-
GC46798
Adapalene-d3
阿达帕林 d3
An internal standard for the quantification of adapalene -
GC46796
Ac-WEHD-AFC (trifluoroacetate salt)
N-Acetyl-Trp-Glu-His-Asp-7-amino-4-Trifluoromethylcoumarin, Caspase1 Substrate (Fluorogenic), Caspase5 Substrate (Fluorogenic)
A neuropeptide with diverse biological activities -
GC46791
Ac-LEHD-pNA (trifluoroacetate salt)
Ac-Leu-Glu-His-Asp-pNA, Caspase-9 Chromogenic Substrate I
A neuropeptide with diverse biological activities -
GC46744
8-Bromoadenosine 5′-triphosphate (sodium salt hydrate)
8-bromo ATP
A neuropeptide with diverse biological activities -
GC46741
8(E),10(E),12(Z)-Octadecatrienoic Acid
α-Calendic Acid, Calendic Acid, Calendulic Acid, trans,trans,cis-8,10,12-Octadecatrienoic Acid
A conjugated PUFA -
GC46705
5-Methoxycanthinone
5-甲氧基铁屎米酮
An alkaloid with anticancer properties -
GC46681
5-Bromouridine
5-溴尿苷
A brominated uridine analog -
GC46583
3-Amino-2,6-Piperidinedione
3-氨基-2,6-哌啶二酮
An active metabolite of (±)-thalidomide -
GC46545
2-Fluoroadenine
2-氟-6-氨基嘌呤
A heterocyclic building block -
GC46528
25-hydroxy Cholesterol-d6
25-羟基胆固醇 d6
An internal standard for the quantification of 25-hydroxy cholesterol -
GC46508
2',2'-Difluoro-2'-deoxyuridine
2'-脱氧-2',2'-二氟尿嘧啶核苷
An active metabolite of gemcitabine - GC46451 16F16 A PDI inhibitor
-
GC46444
15-deoxy-δ12,14-Prostaglandin D2-d9
15-deoxy-Δ12,14-PGD2-d9
A neuropeptide with diverse biological activities -
GC46443
15-deoxy-δ12,14-Prostaglandin D2-d4
15-deoxy-Δ12,14-PGD2-d4
A neuropeptide with diverse biological activities -
GC46379
1,2-Dioleoyl-sn-glycero-3-PS (sodium salt)
1,2-二-(9Z-十八碳烯酰基)-sn-甘油-3-磷酰-L-丝氨酸钠盐
A phospholipid - GC61393 ZZW-115 hydrochloride A NUPR1 inhibitor
- GC61392 ZZW-115 A NUPR1 inhibitor
-
GC61382
Xanthoangelol
黄色当归醇
Xanthoangelol, a chalcone found in the roots of Angelica keiskei, is a nonselective monoamine oxidase (MAO) inhibitor and a potent dopamine β-hydroxylase (DBH) inhibitor. It has anti-inflammatory, antibiotic and pro-apoptotic activities. -
GC61361
Tubuloside B
管花苷B
TubulosideB是可从Cistanchesalsa茎中分离出的天然产物,可抑制TNFα诱导的细胞凋亡。TubulosideB还具有抗氧化活性。 -
GC61352
Triglycidyl isocyanurate
1,3,5-三缩水甘油-S-三嗪三酮,TGIC; Teroxirone
Triglycidyl Isocyanurate (Teroxirone, Tris(2,3-epoxypropyl) Isocyanurate, TGI, TGIC) is a triazene triepoxide with antineoplastic activity. It inhibits growth of human non-small cell lung cancer cells by activating p53. Triglycidyl Isocyanurate alkylates and cross-links DNA, thereby inhibiting DNA replication. Triglycidyl Isocyanurate is also used in various polyester powder coatings in the metal finishing industry. -
GC61349
Tributyrin
甘油三丁酸酯,Glyceryl tributyrate
Glycerol tributyrate (Tributyrin) is a triglyceride that may inhibit cell growth and induce cell differentiation.